The 2021 scenario in targeted therapies for metastatic hepatobiliary and esophageal and gastric cancer
The 2021 scenario in targeted therapies for metastatic hepatobiliary and esophageal and gastric cancer
Expert
Ramon Andrade Bezerra De Mello
Discussant
Maria Thereza Mansur Starling
